1. Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent. Issue 4 (2nd April 2020) Authors: Invernizzi, Rachele; Barnett, Joseph; Rawal, Bhavin; Nair, Arjun; Ghai, Poonam; Kingston, Shaun; Chua, Felix; Wu, Zhe; Wells, Athol U.; Renzoni, Elizabeth R.; Nicholson, Andrew G.; Rice, Alexandra; Lloyd, Clare M.; Byrne, Adam J.; Maher, Toby M.; Devaraj, Anand; Molyneaux, Philip L. Journal: European respiratory journal Issue: Volume 55:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo. (23rd December 2013) Authors: Weiss, Miriam; Blazek, Katrina; Byrne, Adam J.; Perocheau, Dany P.; Udalova, Irina A. Other Names: Ahmed Salahuddin Academic Editor. Journal: Mediators of inflammation Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?. Issue 4 (April 2016) Authors: Byrne, Adam J.; Maher, Toby M.; Lloyd, Clare M. Journal: Trends in molecular medicine Issue: Volume 22:Issue 4(2016) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗